Data from Indias ICMR-INDIAB study (2023) highlights that metabolic disorders including diabetes, hypertension, and dyslipidemia frequently co-exist in obese Indian adults making comprehensive screening even more critical before initiating any pharmacological weight loss treatment
Its important that your diet aligns well with your training
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for type 2 diabetes management (under the brand name Ozempic) and chronic weight management (Wegovy)
Were also a great option for someone who wants to cycle off GLP-1 but sustain the results. Mark Butera, VP, GNC
The resolution of this paradox likely involves dose, individual neurological vulnerability, and the difference between GLP-1 receptor activation in different nervous system compartments
Even if bleeding is not aggressive, people should speak with a doctor to identify the underlying cause